WebApr 3, 2024 · Cilostazol reduces your risk of developing blood clots in the blood vessels of your leg, lungs, heart and brain. You may not feel any difference after taking Cilostazol. However, keep taking this medicine as prescribed by your doctor because you will still be getting its full benefits. Q. WebJun 19, 2024 · Management: Reduce the cilostazol dose to 50 mg twice daily in patients who are also receiving moderate inhibitors of CYP2C19. Monitor clinical response to cilostazol closely. Consider therapy modification. CYP2C19 Inhibitors (Strong): May increase serum concentrations of the active metabolite (s) of Cilostazol.
Cilostazol for Secondary Prevention of Stroke and …
WebJun 16, 2024 · 100 mg orally twice a day at least 30 minutes before or 2 hours after breakfast and dinner. Comments: Patients may respond as early as 2 to 4 weeks after initiation of therapy, but treatment for up to 12 weeks may be required before a beneficial effect is experienced. If symptoms remain unimproved after 3 months, discontinue this drug. WebSep 21, 2024 · Cilostazol is a quinolone derivative primarily used to treat intermittent claudication due to peripheral vascular disease, the FDA-approved indication. Cilostazol … cyndi lauper above the clouds lyrics
Cilostazol for Intermittent Claudication Caused by Peripheral
WebDecrease cilostazol dose by 50%; 3,4-dehydrocilostazol, an active metabolite, increased by 69% as a result of omeprazole inhibition of CYP2C19. fexinidazole. fexinidazole will increase the level or effect of cilostazol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. WebIdentification Summary. Cilostazol is an antiplatelet agent and vasodilator used for the symptomatic relief of intermittent claudication.. Generic Name Cilostazol DrugBank Accession Number DB01166 Background. Cilostazol is a quinolinone derivative and antiplatelet agent with vasodilating properties that has been used in the symptomatic … WebApr 1, 2024 · Cilostazol inhibits platelet aggregation in a reversible manner. Cilostazol has not been studied in patients with hemostatic disorders or active pathologic bleeding. Avoid use of Cilostazol tablets in these … billy k\\u0027s cornwall menu